Zhao Yinlong, Tian Wenbin, Yang Jiankai, Li Xueqing, Lu Huaihai, Yu Ning, Zhang Pei, Liu Chao, Chen Pengfei, Lei Guang, Liu Ya
Department of Anesthesiology and Intensive Care, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Front Microbiol. 2022 Jun 15;13:910419. doi: 10.3389/fmicb.2022.910419. eCollection 2022.
Rhino-orbito-cerebral mucormycosis (ROCM) is an acute, fulminant, opportunistic fungal infection that usually occurs in diabetes or immunocompromised patients. Amphotericin B combined with surgical debridement remains the standard treatment, although it is controversial due to its lager nephrotoxicity. Thus far, no studies have reported the treatment for ROCM-associated fungal endophthalmitis because the exact pathogenesis and transmission routes in ROCM remain unclear. Here, we reported a case of ROCM complicated with fungal endophthalmitis treated favorably with amphotericin B colloidal dispersion (ABCD) in combination with other antifungals and surgical debridement.
A 34-year-old woman with diabetes was admitted to our hospital owing to right-sided headache for 8 days, blindness with swelling in the right eye for 5 days, and blindness in the left eye for 1 day. MRI showed that the patient had sphenoid sinus, sinuses, frontal lobe lesions, and proptosis of the right eye. Metagenomic sequencing revealed that the patient had infection. During hospitalization, the patient received intravenous ABCD, oral posaconazole, and topical amphotericin B and underwent surgical debridement. After 67 days of treatment, the patient's condition was significantly improved, and limb muscle strength showed grade V. showed negative results, and conjunctival swelling decreased. Additionally, no nephrotoxicity occurred during treatment. After discharge, the patient's treatment was transitioned to oral posaconazole and she was free of complaints during the 30-day follow-up without any additional treatment for ROCM.
Treatment with ABCD combined with other antifungal drugs and surgical debridement for ROCM complicated with fungal endophthalmitis showed remarkable efficacy and good safety. Hence, this regimen is a promising treatment strategy for this fatal disease.
鼻眶脑毛霉菌病(ROCM)是一种急性、暴发性、机会性真菌感染,通常发生于糖尿病患者或免疫功能低下者。两性霉素B联合手术清创术仍是标准治疗方法,尽管因其较大的肾毒性存在争议。迄今为止,尚无研究报道ROCM相关真菌性眼内炎的治疗方法,因为ROCM的确切发病机制和传播途径仍不清楚。在此,我们报告1例ROCM合并真菌性眼内炎患者,经两性霉素B胶体分散体(ABCD)联合其他抗真菌药物及手术清创术治疗后效果良好。
一名34岁糖尿病女性因右侧头痛8天、右眼失明伴肿胀5天、左眼失明1天入住我院。磁共振成像(MRI)显示患者蝶窦、鼻窦、额叶有病变,右眼突出。宏基因组测序显示患者有感染。住院期间,患者接受静脉注射ABCD、口服泊沙康唑、局部应用两性霉素B,并接受了手术清创术。治疗67天后,患者病情明显改善,肢体肌力为Ⅴ级。 结果为阴性,结膜肿胀减轻。此外,治疗期间未发生肾毒性。出院后,患者的治疗改为口服泊沙康唑,在30天的随访期间无不适主诉,未针对ROCM进行任何额外治疗。
ABCD联合其他抗真菌药物及手术清创术治疗ROCM合并真菌性眼内炎疗效显著且安全性良好。因此,该治疗方案是治疗这种致命疾病的一种有前景的治疗策略。